For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Enabling Point-of-Care Manufacturing: The Need to Improve QC Assays
Wednesday, May 29, 2024 10:45 AM - 11:45 AM  
Room 212-214
Roundtable
Organized by: ISCT Immuno-Gene Therapy Committee

Moderator   
  • Patrick J. Hanley, PhD, Children’s National Hospital, United States
Panelists
  • Yongping WangMD, PhDCell and Gene Therapy Lab Children's Hospital of Philadelphia, United States
  • Rey Mali, MS, MBA, Accellix, United States
  • Rich Stoner, PhD, United States
Outline the automated, rapid, and complex QC tests whose integration will enable Point-of-Care deployment

Key Learning Objectives

1. Current QC tests being used to release POC products
2. Limitations of existing QC tests
3. Tests that are in development or could be developed to accelerate POC adoption 

Patrick Hanley
Chief & Director, Cellular Therapy Program
Children's National Hospital
Moderator


Rey Mali
Chief Business Officer
Accellix, inc.
Panelist


Rich Stoner
CEO
Exthymic
Panelist


Yongping Wang
Director, Cell and Gene Therapy Lab
Children's Hospital of Philadelphia
Panelist